2-[(1S,12bS)-1-Ethyl-1H,2H,3H,4H,6H,7H,12H,12bH-indolo[2,3-a]quinolizin-1-yl]-N-cyclopentylacetamide

ID: ALA4529035

PubChem CID: 153284543

Max Phase: Preclinical

Molecular Formula: C24H33N3O

Molecular Weight: 379.55

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@@]1(CC(=O)NC2CCCC2)CCCN2CCc3c([nH]c4ccccc34)[C@@H]21

Standard InChI:  InChI=1S/C24H33N3O/c1-2-24(16-21(28)25-17-8-3-4-9-17)13-7-14-27-15-12-19-18-10-5-6-11-20(18)26-22(19)23(24)27/h5-6,10-11,17,23,26H,2-4,7-9,12-16H2,1H3,(H,25,28)/t23-,24+/m1/s1

Standard InChI Key:  VYDBOIQAMVARDZ-RPWUZVMVSA-N

Molfile:  

 
     RDKit          2D

 29 33  0  0  0  0  0  0  0  0999 V2000
   14.9195   -5.5745    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.9236   -4.7495    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2072   -5.1585    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9268   -3.7538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.9256   -4.5811    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6403   -4.9939    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.6385   -3.3410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3538   -3.7502    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.3541   -4.5765    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1401   -4.8317    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   13.1397   -3.4946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.6262   -4.1672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.3019   -2.6541    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.4744   -2.7376    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7884   -3.3266    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.4444   -4.0817    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.7492   -4.6761    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0932   -3.9211    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6117   -3.2432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.2030   -5.9833    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6318   -5.9906    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.6276   -6.8155    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   16.3483   -5.5817    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   16.3399   -7.2315    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4249   -8.0477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2310   -8.2233    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.6471   -7.5109    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.0981   -6.8953    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.0238   -4.7912    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  3  2  1  0
  4  5  2  0
  5  6  1  0
  6  9  2  0
  8  7  2  0
  7  4  1  0
  8  9  1  0
  9 10  1  0
 10 12  1  0
 11  8  1  0
 11 12  2  0
 11 14  1  0
 12 16  1  0
 15 13  1  0
 13 14  1  0
 15 16  1  0
 15 19  1  0
 16  2  1  0
  2 17  1  0
 17 18  1  0
 18 19  1  0
  3 20  1  0
  1 21  1  0
 21 22  1  0
 21 23  2  0
 22 24  1  0
 24 25  1  0
 25 26  1  0
 26 27  1  0
 27 28  1  0
 28 24  1  0
 16 29  1  6
M  END

Alternative Forms

  1. Parent:

    ALA4529035

    ---

Associated Targets(Human)

CCR8 Tchem C-C chemokine receptor type 8 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CHRM4 Tclin Muscarinic acetylcholine receptor M4 (6041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR1 Tclin Cannabinoid CB1 receptor (20913 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CNR2 Tchem Cannabinoid CB2 receptor (16942 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CXCR4 Tclin C-X-C chemokine receptor type 4 (3338 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
DRD2 Tclin Dopamine D2 receptor (23596 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
FPR1 Tchem Formyl peptide receptor 1 (1372 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
GPR119 Tclin Glucose-dependent insulinotropic receptor (4762 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCRTR2 Tclin Orexin receptor 2 (5902 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HRH1 Tclin Histamine H1 receptor (7573 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NPSR1 Tchem Neuropeptide S receptor (15785 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PRLHR Tchem Prolactin-releasing peptide receptor (450 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PTGIR Tclin Prostanoid IP receptor (1280 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 379.55Molecular Weight (Monoisotopic): 379.2624AlogP: 4.71#Rotatable Bonds: 4
Polar Surface Area: 48.13Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 7.20CX LogP: 3.97CX LogD: 3.76
Aromatic Rings: 2Heavy Atoms: 28QED Weighted: 0.81Np Likeness Score: 0.10

References

1. Norwood VM, Brice-Tutt AC, Eans SO, Stacy HM, Shi G, Ratnayake R, Rocca JR, Abboud KA, Li C, Luesch H, McLaughlin JP, Huigens RW..  (2020)  Preventing Morphine-Seeking Behavior through the Re-Engineering of Vincamine's Biological Activity.,  63  (10): [PMID:31913038] [10.1021/acs.jmedchem.9b01924]

Source